Search Results

1,900 Results for "wuxi nextcode".

Sort By

Press Releases

WuXi Biologics Reports Solid 2025 Interim Results

August 20, 2025
·
16 min read
Press Releases

Three WuXi Biologics Manufacturing Facilities Receive GMP Certification from Türkiye İlaç ve Tıbbi Cihaz Kurumu (TITCK)

September 17, 2025
·
3 min read
Manufacturing

Merck Snaps Up WuXi Biologics Facility in Ireland for $500M

The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland.

January 6, 2025
·
1 min read
·
Annalee Armstrong
Press Releases

WuXi AppTec Completes Second RMB1.0 Billion A-Share Repurchase Program in 2025, All Repurchased Shares to Be Cancelled

August 28, 2025
·
1 min read
BIOSECURE Act

WuXi Mulls Sale of Some US, European Operations: FT

The Financial Times reported Thursday that WuXi AppTec is looking to sell its cell and gene therapy manufacturing unit, with facilities in Philadelphia, while WuXi Biologics wants to offload some of its production sites in Europe.

October 3, 2024
·
2 min read
·
Tristan Manalac
Press Releases

WuXi XDC Announces the Mechanical Completion of its Singapore Site, Accelerating the Global Expansion of Bioconjugates Manufacturing

July 1, 2025
·
4 min read
BIOSECURE Act

WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow

WuXi AppTec looks to unload its Philadelphia manufacturing sites and WuXi Biologics slows its rapid expansion in the U.S. as the companies await the Senate’s review of the BIOSECURE Act that threatens to cut them off from U.S. biopharma.

October 8, 2024
·
5 min read
·
Ben Hargreaves
Press Releases

WuXi Biologics Launches Next-Generation Platform WuXiHigh™2.0 for High-Concentration Biologics with Protein Concentration Reaching 230 mg/mL

July 1, 2025
·
3 min read
Podcast

BioSpace at Meeting on the Mesa, WuXi Considers Selling U.S. Facilities, Big Pharma Layoffs, More

Cell and gene therapy investment rebounds; WuXi Biologics and other companies named in BIOSECURE Act mull options; Bayer, J&J and Pfizer’s recent layoffs; updates from the weight loss space.

October 9, 2024
·
1 min read
·
Heather McKenzie
China

WuXi Biologics Takes Net Profit Hit Despite Inking Record Number of New Projects

With the potential passage of the BIOSECURE Act looming, WuXi Biologics reported a 24% drop in net profit in the first half of 2024.

August 22, 2024
·
2 min read
·
Tristan Manalac